Anticoagulation treatment for patients with coronavirus disease 2019 (COVID-19) and its clinical effectiveness in 2020: A meta-analysis study.

Ge, Jingyi; Ma, Yingmin; Wu, Zhipeng; Jin, Jiawei; Sun, Xiao

Ge, Jingyi; Ma, Yingmin; Wu, Zhipeng; Jin, Jiawei; Sun, Xiao.

Afiliação

Ge J; Department of Respiratory Medicine, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, People's Republic of China.
Ma Y; Department of Respiratory and Infections Medicine, Beijing You An Hospital, Capital Medical University, Beijing, People's Republic of China.
Wu Z; Department of Respiratory and Infections Medicine, Beijing You An Hospital, Capital Medical University, Beijing, People's Republic of China.
Jin J; Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, The Clinical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.
Sun X; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA.

Medicine (Baltimore) ; 100(47): e27861, 2021 Nov 24.

Article em En | MEDLINE | ID: mdl-34964754

Assuntos

Anticoagulantes/uso terapêutico; Tratamento Farmacológico da COVID-19; Hemorragia; Humanos; SARS-CoV-2; Resultado do Tratamento; Trombose Venosa

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 4_covid_19 / 6_venous_thromboembolic_disease Assunto principal: Tratamento Farmacológico da COVID-19 / Anticoagulantes Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google